Correlation Between SAB Biotherapeutics and Vyne Therapeutics

Can any of the company-specific risk be diversified away by investing in both SAB Biotherapeutics and Vyne Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SAB Biotherapeutics and Vyne Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between SAB Biotherapeutics and Vyne Therapeutics, you can compare the effects of market volatilities on SAB Biotherapeutics and Vyne Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SAB Biotherapeutics with a short position of Vyne Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of SAB Biotherapeutics and Vyne Therapeutics.

Diversification Opportunities for SAB Biotherapeutics and Vyne Therapeutics

0.65

Correlation Coefficient

SAB Biotherapeutics  Vyne Therapeutics

Poor diversification

The 3 months correlation between SAB and Vyne is 0.65. Overlapping area represents the amount of risk that can be diversified away by holding SAB Biotherapeutics and Vyne Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vyne Therapeutics and SAB Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SAB Biotherapeutics are associated (or correlated) with Vyne Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vyne Therapeutics has no effect on the direction of SAB Biotherapeutics i.e., SAB Biotherapeutics and Vyne Therapeutics go up and down completely randomly.

Pair Corralation between SAB Biotherapeutics and Vyne Therapeutics

Given the investment horizon of 90 days SAB Biotherapeutics is expected to under-perform the Vyne Therapeutics. In addition to that, SAB Biotherapeutics is 1.6 times more volatile than Vyne Therapeutics. It trades about -0.12 of its total potential returns per unit of risk. Vyne Therapeutics is currently generating about -0.1 per unit of volatility. If you would invest  257.00  in Vyne Therapeutics on December 23, 2024 and sell it today you would lose (85.00) from holding Vyne Therapeutics or give up 33.07% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

SAB Biotherapeutics  vs.  Vyne Therapeutics

SAB Biotherapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days SAB Biotherapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's fundamental drivers remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Vyne Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Vyne Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in April 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Pair Trading with SAB Biotherapeutics and Vyne Therapeutics

The main advantage of trading using opposite SAB Biotherapeutics and Vyne Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SAB Biotherapeutics position performs unexpectedly, Vyne Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vyne Therapeutics will offset losses from the drop in Vyne Therapeutics' long position.

The idea behind SAB Biotherapeutics and Vyne Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..